NCT04816604Phase 2Terminated

Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Study sponsor: Gossamer Bio USA, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-09Actual
Enrollment · participants74Actual
Source updated2026-11-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2027. After: 9 Sep 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview